M. Rickenbach

Discipline

Sociologie (2) Economies et finances (2)

Type de document

Articles (27) Colloques et conférences (2)

Co-auteur

Date

Source

Mot-clé

cohorte (25) Swiss (23) Human beings (22) Treatment (21) Methods (21) Methods (21) thérapie (20) adulte (20) Therapeutics (20) adulte (20) Patients (17) Patients (17) Older people (16) risque (15) Immunodeficiency (15) Risk (15) virus (13) infection (11) Infection (11) Confidence (11) temps (durée) (10) âge (10) Ci (Chinese poetry) (10) Time (10) Age (10) Age (10) art (9) Art (9) Art (9) Persons (9)

Documents écrit par M. Rickenbach (29) | parle de M. Rickenbach (0)

HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons.
F. Bihl et al. (2015)
Increases in condomless sex in the Swiss HIV Cohort Study.
R.D. Kouyos et al. (2015)
Incident Hepatitis C Virus Infections in the Swiss HIV Cohort Study : changes in treatment uptake and outcomes between 1991 and 2013
G. Wandeler et al. (2015)
Transient detectable viremia and the risk of viral rebound in patients from the Swiss HIV Cohort Study.
J. Young et al. (2015)
Gender differences in HIV-positive persons in use of cardiovascular disease-related interventions : D:A:D study
C.I. Hatleberg et al. (2014)
Loss to follow-up of HIV-infected women after delivery : The Swiss HIV Cohort Study and the Swiss Mother and Child HIV Cohort Study
R. Kouyos et al. (2014)
Obesity trends and body mass index changes after starting antiretroviral treatment : the Swiss HIV Cohort Study
B. Hasse et al. (2014)
Determinants of sustained viral suppression in HIV-infected patients with self-reported poor adherence to antiretroviral therapy.
T.R. Glass et al.
High specificity of line-immunoassay based algorithms for recent HIV-1 infection independent of viral subtype and stage of disease.
J. Schüpbach et al. (2011)
Impact of international consensus guidelines on antiviral therapy of chronic hepatitis C patients in Switzerland.
K. Overbeck et al. (2010)
Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study.
S. Franceschi et al. (2010)
Impact of previous virological treatment failures and adherence on the outcome of antiretroviral therapy in 2007.
M. Ballif et al. (2009)
Parents living with HIV in a high-income country: do patients need specific support?
D. Gredig et al. (26 janv. 2008)
Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir.
V. von Wyl et al. (2008)
Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy.
S. Franceschi et al. (2008)
Cohort Profile: The Swiss Hepatitis C Cohort Study (SCCS)
L. Prasad et al.
Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study
B. Ledergerber et al.
Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission
L. Elzi et al.
Hepatitis C virus and non-Hodgkin's lymphoma: Findings from the Swiss HIV Cohort Study
S. Franceschi et al.
Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia
M. Rotger et al.
Characteristics, determinants, and clinical relevance of CD4 T cell recovery to
G.R. Kaufmann et al.
Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study
A. Rauch et al.
Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders.
P.E. Tarr et al. (2005)
Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?
E. Fontas et al.
Disseminated M. avium complex infection in the Swiss HIV Cohort Study: declining incidence, improved prognosis and discontinuation of maintenance therapy.
M. Rossi et al. (11 août 2001)

next